IMRX
#3260
Immuneering Corporation - Class A Common Stock
4.9 9 USD
-0.04%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-4.22%
Changement Mensuel
+20.24%
Evolution sur 6 mois
+2.89%
Changement Annuel
-11.52%
Clôture Précédente
5.2 1
Open
4.9 9
Low
4.9 9
High
4.9 9
Volume
41
Financials
- Market Capitalization 322.84 M
- Employee 57
- Founded 2008
- CEO N/A
- Website www.immuneering.com
- Headquarter Delaware, United States
- FIGI BBG009QXJQS1
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3218 |  ABEO Abeona Therapeutics Inc. - Common Stock | 5.92 USD | -1.99% | -3.43% | -8.22% | -13.45% | 338.53 M USD | ||
| 3222 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.41 USD | -2.43% | 0.00% | +10.05% | +36.16% | 336.28 M USD | ||
| 3265 |  VNDA Vanda Pharmaceuticals Inc. - Common Stock | 5.29 USD | -2.76% | -0.94% | +3.73% | -4.34% | 319.85 M USD | ||
| 3293 |  OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 5.19 USD | +1.57% | -2.99% | +28.47% | +92.22% | 311.95 M USD |